| 1.91 0.145 (8.22%) | 11-04 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.41 | 1-year : | 2.82 |
| Resists | First : | 2.06 | Second : | 2.41 |
| Pivot price | 1.73  |
|||
| Supports | First : | 1.54 |
Second : | 1.22 |
| MAs | MA(5) : | 1.69 |
MA(20) : | 1.67 |
| MA(100) : | 1.32 |
MA(250) : | 1.38 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 52.8 |
D(3) : | 44.4 |
| RSI | RSI(14): 61.1 |
|||
| 52-week | High : | 4.5 | Low : | 0.72 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ RDGT ] has closed below upper band by 15.0%. Bollinger Bands are 38.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.99 - 2 | 2 - 2 |
| Low: | 1.62 - 1.63 | 1.63 - 1.64 |
| Close: | 1.9 - 1.91 | 1.91 - 1.92 |
Ridgetech Inc operates as a holding company. The Company, through its subsidiaries, wholesales, distributes, and retails pharmaceutical and other healthcare products.
Tue, 04 Mar 2025
RDGT Stock Price and Chart — NASDAQ:RDGT - TradingView
Mon, 03 Mar 2025
Ridgetech, Inc. Completes Strategic Acquisition and Divestiture, Rebrands from China Jo-Jo Drugstores - TipRanks
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 6 (M) |
| Shares Float | 4 (M) |
| Held by Insiders | 38.4 (%) |
| Held by Institutions | 0.7 (%) |
| Shares Short | 63 (K) |
| Shares Short P.Month | 9 (K) |
| EPS | -0.26 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.05 |
| Profit Margin | 8.5 % |
| Operating Margin | -0.9 % |
| Return on Assets (ttm) | -0.9 % |
| Return on Equity (ttm) | -6.7 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0.65 |
| Sales Per Share | 20.47 |
| EBITDA (p.s.) | 0.01 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1 (M) |
| Levered Free Cash Flow | -19 (M) |
| PE Ratio | -7.35 |
| PEG Ratio | 0 |
| Price to Book value | 0.37 |
| Price to Sales | 0.09 |
| Price to Cash Flow | 8.95 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|